The efficacy of immune checkpoint inhibitors in biliary tract cancer with KRAS mutation.

Sun Young Jeong,Seung Tae Kim,Jae Yeon Jang

Therapeutic advances in gastroenterology（2023）

引用 1|浏览5

暂无评分

摘要

Our analysis suggested that PD-L1 expression might be a useful biomarker for ICIs in BTC patients with KRAS mutation but not in those with wild-type KRAS.

查看译文

关键词

biliary tract cancer,immune checkpoint inhibitors,kras mutation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要